Insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) play an important role in cell growth and differentiation. Clinical and epidemiological studies have indicated that measuring IGFs and IGFBPs in blood has potential implications in assessing growth-related abnormalities and risks o
Enhanced insulin-like growth factor-I (IGF-I) cell association at reduced pH is dependent on IGF binding protein-3 (IGFBP-3) interaction
✍ Scribed by Kimberly Forsten-Williams; Theresa R. Cassino; Laura J. Delo; Abigail D. Bellis; Anne S. Robinson; Thomas E. Ryan
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 256 KB
- Volume
- 210
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The cellular microenvironment impacts how signals are transduced by cells and plays a key role in tissue homeostasis. Although pH is generally well regulated, there are a number of situations where acidosis occurs and our work addresses how low pH impacts cell association of insulin‐like growth factor‐I (IGF‐I) in the presence of IGF binding protein‐3 (IGFBP‐3). We have previously shown that IGF‐I cell binding was enhanced in the presence of IGFBP‐3 at low pH and now show that this binding is IGFBP‐mediated as it is inhibited by Y60L‐IGF‐I, a mutant with reduced affinity for the IGF receptor (IGF‐IR), and unaffected by insulin, which binds but not IGFBPs. Using surface plasmon resonance (SPR), we show that direct binding between IGF‐I and IGFBP‐3 is pH sensitive. Despite this, the key step in the process appears to be IGFBP‐3 cell surface association as Long‐R^3^‐IGF‐I, a mutant with reduced affinity for IGFBPs, shows a similar increase in cell association at pH 5.8 in the presence of IGFBP‐3 but does not exhibit pH‐dependent binding by SPR. Further, analysis indicates a large increase in low‐affinity binding sites for IGF‐I in the presence of IGFBP‐3 and an elimination of IGF‐I enhanced binding when a non‐cell associating mutant of IGFBP‐3 is added in place of IGFBP‐3. That the IGFBP‐3‐mediated binding localizes IGF‐I away from IGF‐IR is suggested by triton‐solubility testing and indicates additional complexities to IGF‐I regulation by IGFBP‐3. Identifying the pH‐dependent binding partner(s) for IGFBP‐3 is a necessary next step in deciphering this process. J. Cell. Physiol. 210: 298–308, 2007. © 2006 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract While extracellular acidification within solid tumors is well‐documented, how reduced pH impacts regulation of insulin‐like growth factor‐I (IGF‐I) has not been studied extensively. Because IGF‐I receptor binding is affected by IGF binding proteins (IGFBPs), we examined how pH impacted
Insulin-like growth factor binding protein (IGFBP)-3 effects proliferation and differentiation of numerous cell types by binding to insulin-like growth factors (IGF) and attenuating their activity or by directly affecting cells in an IGFindependent manner. Consequently, IGFBPs produced by specific c
IGF-I is mitogenic for the bovine mammary epithelial cell line MAC-T. In addition, IGF-I specifically upregulates IGFBP-3 synthesis in these cells. To investigate this effect on cell growth and IGF-I responsiveness, cell lines were developed that constitutively express IGFBP-3. MAC-T cells transfect
## Abstract Insulin‐like growth factor binding protein‐5 (IGFBP‐5) and thrombospondin‐1 (TS‐1) are both present in extracellular matrix (ECM). Both proteins have been shown to bind to one another with high affinity. The purpose of these studies was to determine how the interaction between IGFBP‐5 a